Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merel van Diepen

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Diabetes Care|October 21, 2020
Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955Edouard L Fu, Merel van Diepen
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 17, 2023
Predicting Kidney Failure With the Kidney Failure Risk Equation: Time to Rethink ProbabilitiesRoemer J Janse, Merel van Diepen, Chava L Ramspek
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
Con: Most clinical risk scores are uselessFriedo W Dekker, Chava L Ramspek, Merel van Diepen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
Opponent's commentsFriedo W Dekker, Chava L Ramspek, Merel van Diepen
Frontiers in Health Services|February 2, 2026
Perceived barriers to management of patients with diabetes mellitus and hypertension in primary care centers in IndonesiaNi Made Hustrini, Endang Susalit, Merel van Diepen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Relative risk versus absolute risk: one cannot be interpreted without the otherMarlies Noordzij, Merel van Diepen, Fergus C Caskey, et al.
Chest|October 11, 2016
Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease: The Problem of Observational StudiesChristiaan Lucas Meuwese, Judith Kooiman, Merel van Diepen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
Erratum to: Relative risk versus absolute risk: one cannot be interpreted without the otherMarlies Noordzij, Merel van Diepen, Fergus C Caskey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2019
Towards the best kidney failure prediction tool: a systematic review and selection aidChava L Ramspek, Ype de Jong, Friedo W Dekker, et al.
Journal of Clinical Epidemiology|May 10, 2025
Prediction model Risk Of Bias ASsessment Tool (PROBAST) shows high interrater reliability when scored by international experts on prediction modelingYpe de Jong, Liselotte F S Langenhuijsen, Esmee Venema, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Diabetes Care|October 21, 2020
Comment on Kwon et al. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease. Diabetes Care 2020;43:948-955Edouard L Fu, Merel van Diepen
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 17, 2023
Predicting Kidney Failure With the Kidney Failure Risk Equation: Time to Rethink ProbabilitiesRoemer J Janse, Merel van Diepen, Chava L Ramspek
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
Con: Most clinical risk scores are uselessFriedo W Dekker, Chava L Ramspek, Merel van Diepen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 13, 2017
Opponent's commentsFriedo W Dekker, Chava L Ramspek, Merel van Diepen
Frontiers in Health Services|February 2, 2026
Perceived barriers to management of patients with diabetes mellitus and hypertension in primary care centers in IndonesiaNi Made Hustrini, Endang Susalit, Merel van Diepen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 25, 2017
Relative risk versus absolute risk: one cannot be interpreted without the otherMarlies Noordzij, Merel van Diepen, Fergus C Caskey, et al.
Chest|October 11, 2016
Warfarin for Atrial Fibrillation in Patients With End-Stage Renal Disease: The Problem of Observational StudiesChristiaan Lucas Meuwese, Judith Kooiman, Merel van Diepen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
Erratum to: Relative risk versus absolute risk: one cannot be interpreted without the otherMarlies Noordzij, Merel van Diepen, Fergus C Caskey, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 5, 2019
Towards the best kidney failure prediction tool: a systematic review and selection aidChava L Ramspek, Ype de Jong, Friedo W Dekker, et al.
Journal of Clinical Epidemiology|May 10, 2025
Prediction model Risk Of Bias ASsessment Tool (PROBAST) shows high interrater reliability when scored by international experts on prediction modelingYpe de Jong, Liselotte F S Langenhuijsen, Esmee Venema, et al.
Pageof 11